Exact Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Exact Sciences generated cash of $156,119,000, which is more than the previous year. Cash used in financing activities reached the amount of $159,766,000 last year. Net change in cash is therefore $366,885,000.
Cash Flow
| 2014 | -80.91M | -117.83M | 244.02M |
|---|---|---|---|
| 2015 | -134.01M | -64.75M | 181.76M |
| 2016 | -130.06M | -11.51M | 149.58M |
| 2017 | -71.72M | -160.80M | 260.95M |
| 2018 | -69.32M | -781.91M | 934.14M |
| 2019 | -115.01M | -121.07M | 253.18M |
| 2020 | 136.48M | -702.03M | 1.87B |
| 2021 | -102.23M | -1.08B | 8.47M |
| 2022 | -223.55M | 74.06M | 76.48M |
| 2023 | 156.11M | 49.67M | 159.76M |
EXAS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 242.79M | 315.76M | 1.49B | 177.52M | 160.43M | 77.49M | 48.92M | 41.13M | 58.13M | 12.85M |
Operating activities | ||||||||||
Net income | -204.14M | -623.50M | -595.62M | -848.53M | -83.99M | -175.14M | -114.39M | -167.21M | -157.80M | -100.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 206.60M | 197.55M | 180.34M | 163.36M | 50.24M | 23.08M | 15.55M | 11.50M | 7.75M | 3.71M |
Stock-based compensation expense | 231.31M | 206.82M | 253.06M | 152.90M | 108.48M | 0 | 35.51M | 23.73M | 18.05M | 11.52M |
| Deferred income tax benefit | 231.31M | 206.82M | 253.06M | 152.90M | 108.48M | 0 | 35.51M | 23.73M | 18.05M | 11.52M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -43.41M | 61.08M | 25.15M | -100.52M | -27.93M | -17.29M | -17.52M | -3.59M | -3.55M | -1.37M |
Inventories | -7.69M | -13.23M | -9.22M | -30.31M | -19.04M | -12.72M | -19.19M | -156K | -2.66M | -4.01M |
Accounts payable | 82.75M | -52.18M | 153.11M | 46.38M | -645K | 11.33M | 15.38M | -2.59M | 661K | 1.88M |
Cash generated by operating activities | 156.11M | -223.55M | -102.23M | 136.48M | -115.01M | -69.32M | -71.72M | -130.06M | -134.01M | -80.91M |
Investing activities | ||||||||||
Purchases Of Investments | -139.85M | -131.48M | -1.16B | -1.08B | -634.11M | -1.19B | -357.05M | -189.98M | -205.05M | -209.47M |
Investments In Property Plant And Equipment | -124.19M | -214.46M | -135.76M | -64.35M | -171.80M | -150.67M | -69.24M | -14.85M | -21.98M | -12.53M |
Acquisitions Net | -68.97M | -57.50M | -517.77M | -22.60M | -973.86M | -17.90M | -5.98M | 230K | 1.9M | -240K |
Cash generated by investing activities | 49.67M | 74.06M | -1.08B | -702.03M | -121.07M | -781.91M | -160.80M | -11.51M | -64.75M | -117.83M |
Financing activities | ||||||||||
Common Stock Issued | 31.54M | 6.52M | 37.50M | 861.70M | 17.18M | 4.30M | 253.38M | 0 | 174.14M | 238.58M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 28.34M | 25.49M | 23.07M | 18.35M | 8.39M | 4.89M | 0 | 0 | 0 | 760K |
Repayments of term debt | 137.97M | 50M | -23.74M | -150.05M | 236.12M | -4.81M | -376K | -166K | 4.65M | -351K |
Cash used in financing activities | 159.76M | 76.48M | 8.47M | 1.87B | 253.18M | 934.14M | 260.95M | 149.58M | 181.76M | 244.02M |
Net Change In Cash | 366.88M | -72.97M | -1.17B | 1.31B | 17.09M | 82.93M | 28.57M | 7.78M | -16.99M | 45.28M |
Cash at end of period | 609.67M | 242.79M | 315.76M | 1.49B | 177.52M | 160.43M | 77.49M | 48.92M | 41.13M | 58.13M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |